Linking NLRP3 inflammasome and pulmonary fibrosis: mechanistic insights and promising therapeutic avenues
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Immunology
Link
https://link.springer.com/content/pdf/10.1007/s10787-023-01389-5.pdf
Reference170 articles.
1. Abdelhady R, Cavalu S, Saber S et al (2023) Mirtazapine, an atypical antidepressant, mitigates lung fibrosis by suppressing NLPR3 inflammasome and fibrosis-related mediators in endotracheal bleomycin rat model. Biomed Pharmacother 161:114553. https://doi.org/10.1016/j.biopha.2023.114553
2. Accolla RS, Ramia E, Tedeschi A, Forlani G (2019) CIITA-driven MHC class II expressing tumor cells as antigen presenting cell performers: toward the construction of an optimal anti-tumor vaccine. Front Immunol 10:1806. https://doi.org/10.3389/fimmu.2019.01806
3. Alyaseer AAA, de Lima MHS, Braga TT (2020) The role of NLRP3 inflammasome activation in the epithelial to mesenchymal transition process during the fibrosis. Front Immunol 11:883. https://doi.org/10.3389/fimmu.2020.00883
4. Artlett CM (2022) The mechanism and regulation of the NLRP3 inflammasome during fibrosis. Biomolecules 12(5):634. https://doi.org/10.3390/biom12050634
5. Bailly C (2019) Cepharanthine: an update of its mode of action, pharmacological properties and medical applications. Phytomedicine 62:152956. https://doi.org/10.1016/j.phymed.2019.152956
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3